<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27849302</article-id><article-id pub-id-type="pmc">5094420</article-id><article-id pub-id-type="doi">10.5935/1678-9741.20160063</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Surgery for Tetralogy of Fallot in Adults: Early
Outcomes</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Khan</surname><given-names>Imran</given-names></name><degrees>FCPS</degrees><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="c1"/></contrib><contrib contrib-type="author"><name><surname>Tufail</surname><given-names>Zafar</given-names></name><degrees>FRCS</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Afridi</surname><given-names>Saeed</given-names></name><degrees>MS</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Iqbal</surname><given-names>Madiha</given-names></name><degrees>MSc</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Khan</surname><given-names>Tipu</given-names></name><degrees>MS</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Waheed</surname><given-names>Abdul</given-names></name><degrees>FCPS</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><aff id="aff1"><label>1</label> Punjab Institute of Cardiology, Lahore, Pakistan. </aff></contrib-group><author-notes><corresp id="c1"><bold>Correspondence Address:</bold> Imran Khan, Room No. B-2, Old
Doctor Hostel, Punjab Institute of Cardiology, Jail Road, Lahore, Pakistan,
Email: <email>imran_kmc@hotmail.com</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Jul-Sep</season><year>2016</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Jul-Sep</season><year>2016</year></pub-date><volume>31</volume><issue>4</issue><fpage>300</fpage><lpage>303</lpage><history><date date-type="received"><day>31</day><month>1</month><year>2016</year></date><date date-type="accepted"><day>11</day><month>5</month><year>2016</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><sec><title>Objective</title><p>To study the in-hospital outcome of adult patients who had undergone surgical
repair for Tetralogy of Fallot.</p></sec><sec><title>Methods</title><p>A retrospective descriptive study was conducted at the Punjab Institute of
Cardiology searching the hospital records. All those adult patients who had
undergone repair for Tetralogy of Fallot from January 2012 to December 2014
were included in the study. All the patients were operated by the same
surgical team. Patients who underwent primary repair as well as those with
previous palliative procedures were included in the study. Thirty days
outcome was studied by recording variables from the database. Data was
analysed using Statistical Package for Social Sciences version 16.</p></sec><sec><title>Results</title><p>A total of 80 patients was included in the study, in which there were 48
(60%) male patients and 32 (40%) female patients. Mean age was
21&#x000b1;0.21 years. Those with previous palliation were 15 (18.75%). The
associated problems observed were: atrial septal defect 27 (33.75%), right
aortic arch 30 (37.5%), patent ductus arteriosus 6 (7.5%) and double outlet
right ventricle 3 (3.75%). In-hospital mortality recorded was 7 (8%).
Postoperative complications encountered were low cardiac output syndrome 9
(11.25%), pleural effusion requiring tapping 3 (3.75%), reoperation for
bleeding 3 (3.8%), pulmonary regurgitation (moderate to severe) 20 (25%)
which occurred in the transannular patch group only and atrial arrhythmia 4
(5%).</p></sec><sec><title>Conclusion</title><p>A large number of adult patients are still operated for tetralogy of Fallot
in Pakistan. With increasing experience in the technique the mortality and
morbidity is comparable to international literature.</p></sec></abstract><kwd-group><kwd>Tetralogy of Fallot</kwd><kwd>Adult</kwd><kwd>Hospital Mortality</kwd></kwd-group></article-meta></front><body><table-wrap id="t3" orientation="portrait" position="anchor"><table frame="hsides" rules="groups" style="background-color:#e6e7e8"><colgroup span="1"><col width="10%" span="1"/><col width="90%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Abbreviations, acronyms &#x00026; symbols</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">AVSD</td><td align="left" rowspan="1" colspan="1">=Atrioventricular septal defect</td></tr><tr><td align="left" rowspan="1" colspan="1">LAD</td><td align="left" rowspan="1" colspan="1">=Left anterior descending</td></tr><tr><td align="left" rowspan="1" colspan="1">MAPCAS</td><td align="left" rowspan="1" colspan="1">=Major aortopulmonary collateral arteries</td></tr><tr><td align="left" rowspan="1" colspan="1">PA</td><td align="left" rowspan="1" colspan="1">=Pulmonary artery</td></tr><tr><td align="left" rowspan="1" colspan="1">PR</td><td align="left" rowspan="1" colspan="1">=Pulmonary regurgitation</td></tr><tr><td align="left" rowspan="1" colspan="1">RCA</td><td align="left" rowspan="1" colspan="1">=Right coronary artery</td></tr><tr><td align="left" rowspan="1" colspan="1">RV</td><td align="left" rowspan="1" colspan="1">=Right ventricular</td></tr><tr><td align="left" rowspan="1" colspan="1">RVOT</td><td align="left" rowspan="1" colspan="1">=Right ventricular outflow tract</td></tr><tr><td align="left" rowspan="1" colspan="1">TAP</td><td align="left" rowspan="1" colspan="1">=Transannular patch</td></tr><tr><td align="left" rowspan="1" colspan="1">ToF</td><td align="left" rowspan="1" colspan="1">=Tetralogy of Fallot</td></tr><tr><td align="left" rowspan="1" colspan="1">VSD</td><td align="left" rowspan="1" colspan="1">=Ventricular septal defect</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>Paediatric cardiac surgery started in Pakistan in the 80's. Since then our
competencies in this particular field of cardiac surgery have improved a great deal.
Because of the comparatively recent introduction of congenital cardiac surgery in
Pakistan, the surgery of congenital cardiac problems in adults has been an area of
interest in many centers in the country.</p><p>Tetralogy of Fallot (ToF) is the most frequent cyanotic congenital heart disease,
constituting 7 to 10% of all the congenital heart diseases<sup>[<xref rid="B1" ref-type="bibr">1</xref>]</sup>. It carries a very high mortality
if left untreated. The 10-year survival in patients untreated is 24% only<sup>[<xref rid="B2" ref-type="bibr">2</xref>]</sup>. The basic anatomical defects stems
from the anterior and superior deviation of the infundibular septum which results in
the four main features of the disease i.e. subvalvar pulmonary stenosis with
hypoplasia of pulmonary artery (PA) valve and pulmonary arteries, non-restrictive
malalignment sub-arterial ventricular septal defect (VSD), overriding aorta and
right ventricular (RV) hypertrophy. Cyanosis is the main physical feature of the
disease whose severity is determined by the degree of right ventricular outflow
tract (RVOT) obstruction stenosis, which determines the right to left shunt.
Associated anomalies are secundum atrial septal defect, right aortic arch (25%),
major aortopulmonary collateral arteries (MAPCAS), complete atrioventricular septal
defect (AVSD), anomaly of coronary arteries with <italic>e.g</italic>. anomalous
left anterior descending (LAD) from right coronary artery (RCA) crossing the RVOT
(5%)<sup>[<xref rid="B3" ref-type="bibr">3</xref>]</sup>. Cardiac magnetic
resonance is the gold standard assessment tool based on its superior imaging of the
RVOT, pulmonary arteries, aorta, and aortopulmonary collateral arteries, and on its
ability to quantify biventricular size and function, pulmonary regurgitation (PR),
and myocardial viability<sup>[<xref rid="B4" ref-type="bibr">4</xref>]</sup>.
Primary repair is the strategy of choice where possible in the first year of life.
Patients with unfavourable anatomy, comorbidities and severe cyanosis undergo a
palliative shunt procedure before the definitive corrective surgery later on in
life.</p><p>The purpose of this report was to know the outcome of corrective surgery for ToF in
our setup in terms of short-term mortality and morbidity. To the best of our
knowledge, this is the largest report so far about ToF repair in adult patients in
Pakistan.</p></sec><sec sec-type="methods"><title>METHODS</title><p>A retrospective descriptive study was designed to study the in-hospital outcome of
all the adult patients who had undergone surgical correction for ToF from January
2012 to December 2014. The hospital database of the Punjab Institute of Cardiology
was searched for this purpose and patient variables were recorded. Being a
retrospective study, individual patient consent was waived by the hospital ethical
review committee.</p><p>The basic surgical steps were identical in all the patients <italic>i.e.</italic> use
of cardiopulmonary bypass and avoiding ventriculotomy in most patients. Patients who
had undergone palliative procedure previously were evaluated for hemodynamic
parameters and size of PA. Those without any irreversible pulmonary arterial
hypertension and unfavourable pulmonary anatomy were subjected to final corrective
procedure. The goal of repair was a complete relief of RVOT and closure of VSD.
Patients with only subpulmonic narrowing underwent infundibular resection of the
myocardium. Patients with narrowing of the pulmonary valve annulus also underwent
pulmonary valvotomy or placement of a transannular patch (TAP). In these cases, a
relief of pulmonary obstruction was achieved at the cost of varying degrees of
pulmonary insufficiency.</p><p>Perioperative variables were recorded and data analysed using Statistical Package for
Social Sciences version 16. Quantitative variable were presented as mean &#x000b1;
standard deviation and the qualitative variables were presented as frequency and
percentages. For the comparison of the quantitative data, independent sample t-test
was applied while for qualitative data chi-square was used. A
<italic>P</italic>-value &#x02264; 0.05 was considered significant.</p></sec><sec sec-type="results"><title>RESULTS</title><p>A total of 80 patients were included in the study. Most of the patients included were
male, 48 (60%), while female patients were 32 (40%). Preoperative characteristics
are shown in <xref ref-type="table" rid="t1">Table 1</xref>. Mean age of the
patients was 21&#x000b1;0.21 years with a range of 12 to 43 years. Patients were
divided into 3 based on whether they received a TAP, only RVOT patch or no patch at
all. Among the 80 patients, 15 patients had already undergone a palliative surgical
procedure so they underwent a complete corrective surgery or two-stage procedure.
Different morphological forms identified in our patients were: main PA stenosis 24
(30.0%), right PA stenosis 14 (17.5%), left PA stenosis 12 (15%), MAPCAS 5 (6.25%),
right aortic arch 30 (37.5%), aberrant subclavian artery 3 (3.75%), atrial septal
defect 27 (33.75%), left superior vena cava 5 (6.25%), patent ductus arteriosus 6
(7.5%), and double outlet right ventricle 3 (3.75%). A right aortic arch, atrial
septal defect and main PA stenosis were the most common associated malformations
observed. No pericardial RVOT or TAP was used in 23 (28.75%) patients. TAP for
narrow pulmonary annulus was used in 29 (36.25%) and RVOT patch was used in 28
(35.0%) patients. Most of the patients underwent a patch enlargement of
infundibular-pulmonary outflow tract. Complications noted in the postoperative
period were low cardiac output syndrome 9 (11.25%), heart block 4 (5.0%), pleural
effusion requiring tapping in 3 (3.75%), atrial arrhythmia 4 (5%), reoperation for
bleeding 3 (3.8%) and PR (moderate to severe) 20 (25%). Mortality observed during
the 30 days in the postoperative period was 7 (8%) (<xref ref-type="table" rid="t2">Table 2</xref>).</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Patient characteristics.</p></caption><table frame="hsides" rules="cols"><colgroup span="1"><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/></colgroup><thead><tr style="border-bottom-width:thin;border-bottom-style:solid"><th align="left" colspan="2" rowspan="1">Characteristic</th><th align="center" rowspan="1" colspan="1">Number of patients</th><th align="center" rowspan="1" colspan="1">No patch</th><th align="center" rowspan="1" colspan="1">Transannular patch</th><th align="center" rowspan="1" colspan="1">RVOT patch</th><th align="center" rowspan="1" colspan="1"><italic>P</italic>-value</th></tr></thead><tbody><tr style="border-bottom-width:thin;border-bottom-style:solid"><td align="left" colspan="2" rowspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">80 (100%)</td><td align="center" rowspan="1" colspan="1">23 (28.75%)</td><td align="center" rowspan="1" colspan="1">29 (36.25%)</td><td align="center" rowspan="1" colspan="1">28 (35.0%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr style="border-bottom-width:thin;border-bottom-style:solid"><td style="border-left-width:thin;border-left-style:solid" align="left" colspan="2" rowspan="1">Mean age (range; 12-43) year</td><td align="center" rowspan="1" colspan="1">21&#x000b1;0.21</td><td align="center" rowspan="1" colspan="1">14&#x000b1;0.32</td><td align="center" rowspan="1" colspan="1">17&#x000b1;0.41</td><td align="center" rowspan="1" colspan="1">19&#x000b1;0.44</td><td align="center" rowspan="1" colspan="1">0.001<xref ref-type="table-fn" rid="TFN1">&#x000a7;</xref></td></tr><tr style="border-bottom-width:thin;border-bottom-style:solid"><td style="border-left-width:thin;border-left-style:solid" align="left" rowspan="1" colspan="1">Gender</td><td style="border-left-width:thin;border-left-style:solid" align="left" rowspan="1" colspan="1">Male</td><td align="center" rowspan="1" colspan="1">48 (60%)</td><td align="center" rowspan="1" colspan="1">15 (65.2%)</td><td align="center" rowspan="1" colspan="1">16 (55.2%)</td><td align="center" rowspan="1" colspan="1">17 (60.71%)</td><td align="center" rowspan="1" colspan="1">0.182<xref ref-type="table-fn" rid="TFN2">#</xref></td></tr><tr style="border-bottom-width:thin;border-bottom-style:solid"><td align="left" colspan="2" rowspan="1">Previous palliation</td><td align="center" rowspan="1" colspan="1">15 (18.75%)</td><td align="center" rowspan="1" colspan="1">6 (40.0%)</td><td align="center" rowspan="1" colspan="1">5 (33.3%)</td><td align="center" rowspan="1" colspan="1">4 (57.14%)</td><td align="center" rowspan="1" colspan="1">0.035</td></tr><tr><td align="left" colspan="2" rowspan="1">Morphology</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" colspan="2" rowspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Main
pulmonary artery stenosis</td><td align="center" rowspan="1" colspan="1">24 (30.0%)</td><td align="center" rowspan="1" colspan="1">7 (30.43%)</td><td align="center" rowspan="1" colspan="1">9 (31.03%)</td><td align="center" rowspan="1" colspan="1">9 (28.57%)</td><td align="center" rowspan="1" colspan="1">0.059</td></tr><tr><td align="left" colspan="2" rowspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Right
pulmonary artery stenosis</td><td align="center" rowspan="1" colspan="1">14 (17.5%)</td><td align="center" rowspan="1" colspan="1">3 (13.0%)</td><td align="center" rowspan="1" colspan="1">5 (17.8%)</td><td align="center" rowspan="1" colspan="1">6 (20.6%)</td><td align="center" rowspan="1" colspan="1">0.033</td></tr><tr><td align="left" colspan="2" rowspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Left
pulmonary artery stenosis</td><td align="center" rowspan="1" colspan="1">12 (15%)</td><td align="center" rowspan="1" colspan="1">2 (8.6%)</td><td align="center" rowspan="1" colspan="1">4 (13.7%)</td><td align="center" rowspan="1" colspan="1">6 (20.6%)</td><td align="center" rowspan="1" colspan="1">0.002</td></tr><tr><td align="left" colspan="2" rowspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Major
aortopulmonary collateral arteries</td><td align="center" rowspan="1" colspan="1">5 (6.25%)</td><td align="center" rowspan="1" colspan="1">1 (4.3%)</td><td align="center" rowspan="1" colspan="1">2 (6.8%)</td><td align="center" rowspan="1" colspan="1">3 (10.6%)</td><td align="center" rowspan="1" colspan="1">0.028</td></tr><tr><td align="left" colspan="2" rowspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Right
aortic arch</td><td align="center" rowspan="1" colspan="1">30 (37.5%)</td><td align="center" rowspan="1" colspan="1">7 (30.43%)</td><td align="center" rowspan="1" colspan="1">10 (34.48%)</td><td align="center" rowspan="1" colspan="1">13 (46.42%)</td><td align="center" rowspan="1" colspan="1">0.001</td></tr><tr><td align="left" colspan="2" rowspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Aberrant
subclavian artery</td><td align="center" rowspan="1" colspan="1">3 (3.75%)</td><td align="center" rowspan="1" colspan="1">1 (4.34%)</td><td align="center" rowspan="1" colspan="1">1 (3.57%)</td><td align="center" rowspan="1" colspan="1">1 (3.45%)</td><td align="center" rowspan="1" colspan="1">1.457</td></tr><tr><td align="left" colspan="2" rowspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Atrial
septal defect</td><td align="center" rowspan="1" colspan="1">27 (33.75%)</td><td align="center" rowspan="1" colspan="1">6 (30.43%)</td><td align="center" rowspan="1" colspan="1">10 (34.48%)</td><td align="center" rowspan="1" colspan="1">11 (39.28%)</td><td align="center" rowspan="1" colspan="1">0.032</td></tr><tr><td align="left" colspan="2" rowspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Left
superior vena cava</td><td align="center" rowspan="1" colspan="1">5 (6.25%)</td><td align="center" rowspan="1" colspan="1">1 (4.34%)</td><td align="center" rowspan="1" colspan="1">2 (6.8%)</td><td align="center" rowspan="1" colspan="1">2 (7.1%)</td><td align="center" rowspan="1" colspan="1">0.119</td></tr><tr><td align="left" colspan="2" rowspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Patent
ductus arteriosus</td><td align="center" rowspan="1" colspan="1">6 (7.5%)</td><td align="center" rowspan="1" colspan="1">2 (8.6%)</td><td align="center" rowspan="1" colspan="1">2 (6.8%)</td><td align="center" rowspan="1" colspan="1">2 (7.1%)</td><td align="center" rowspan="1" colspan="1">0.456</td></tr><tr><td align="left" colspan="2" rowspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Double
outlet right ventricle</td><td align="center" rowspan="1" colspan="1">3 (3.75%)</td><td align="center" rowspan="1" colspan="1">1 (4.34%)</td><td align="center" rowspan="1" colspan="1">1 (3.57%)</td><td align="center" rowspan="1" colspan="1">1 (3.45%)</td><td align="center" rowspan="1" colspan="1">1.457</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><label>&#x000a7;</label><p>=one way Anova,</p></fn><fn id="TFN2"><label>#</label><p>=for chi-square test</p></fn></table-wrap-foot></table-wrap><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Major postoperative complications.</p></caption><table frame="hsides" rules="cols"><colgroup span="1"><col width="50%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/></colgroup><thead><tr style="border-bottom-width:thin;border-bottom-style:solid"><th align="left" rowspan="1" colspan="1">Characteristic</th><th align="center" rowspan="1" colspan="1">Number of patients</th><th align="center" rowspan="1" colspan="1">No patch</th><th align="center" rowspan="1" colspan="1">Transannular patch</th><th align="center" rowspan="1" colspan="1">RVOT patch</th><th align="center" rowspan="1" colspan="1"><italic>P</italic>-value</th></tr></thead><tbody><tr style="border-bottom-width:thin;border-bottom-style:solid"><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">80 (100%)</td><td align="center" rowspan="1" colspan="1">23 (28.75%)</td><td align="center" rowspan="1" colspan="1">29 (36.25%)</td><td align="center" rowspan="1" colspan="1">28 (35.0%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Postoperative complications</bold></td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Low cardiac output
syndrome</td><td align="center" rowspan="1" colspan="1">9 (11.25%)</td><td align="center" rowspan="1" colspan="1">2 (8.6%)</td><td align="center" rowspan="1" colspan="1">3 (10.34%)</td><td align="center" rowspan="1" colspan="1">4 (14.28%)</td><td align="center" rowspan="1" colspan="1">0.023</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Heart block</td><td align="center" rowspan="1" colspan="1">4 (5.0%)</td><td align="center" rowspan="1" colspan="1">1 (4.34%)</td><td align="center" rowspan="1" colspan="1">2 (6.8%)</td><td align="center" rowspan="1" colspan="1">1 (3.57%)</td><td align="center" rowspan="1" colspan="1">0.058</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Pleural effusion
requiring tapping</td><td align="center" rowspan="1" colspan="1">3 (3.75%)</td><td align="center" rowspan="1" colspan="1">1 (4.34%)</td><td align="center" rowspan="1" colspan="1">1 (3.57%)</td><td align="center" rowspan="1" colspan="1">1 (3.57%)</td><td align="center" rowspan="1" colspan="1">1.457</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Atrial arrhythmia</td><td align="center" rowspan="1" colspan="1">4 (5%)</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">2 (50%)</td><td align="center" rowspan="1" colspan="1">2 (50%)</td><td align="center" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Reoperation for
bleeding</td><td align="center" rowspan="1" colspan="1">3 (3.8%)</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">2 (6.8%)</td><td align="center" rowspan="1" colspan="1">1 (3.45%)</td><td align="center" rowspan="1" colspan="1">0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Pulmonary regurgitation
(moderate to severe)</td><td align="center" rowspan="1" colspan="1">20 (25%)</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">20 (25%)</td><td align="center" rowspan="1" colspan="1">0.001</td></tr></tbody></table></table-wrap></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>Our study looked into the results of ToF repair in adults only in terms of
in-hospital mortality and complications. The survival of patients with ToF repair
has greatly improved over the years. During a period from 1955 to 1968, the
mortality for primary repair of ToF in the Hospital for Sick Children in Toronto was
35%, but from then onwards, the figure dropped to 12%<sup>[<xref rid="B5" ref-type="bibr">5</xref>]</sup>. The mortality rates of various cardiac centers
decreased with more experience in the procedure. Dittrich et al.<sup>[<xref rid="B6" ref-type="bibr">6</xref>]</sup> reported a mortality of 16% in the
late 90's. The mortality has greatly improved in most recent reports, largely due to
improved technique as well as advances in perioperative care. In the current
literature, mortality as low as 0.8% and as high as 9% has been described<sup>[<xref rid="B7" ref-type="bibr">7</xref>,<xref rid="B8" ref-type="bibr">8</xref>]</sup>. We report a mortality of 8%, which is still high compared to
mortality in paediatric age group. Dittrich et al.<sup>[<xref rid="B6" ref-type="bibr">6</xref>]</sup> argue that this comparatively high mortality in
adults may be because of the problems caused by the long-standing cyanosis. These
include RV dysfunction in the form of fibrosis, cerebral complications like stroke
and abscess formation and poor development of the PA. Our study does not look into
the details of preoperative RV function or history of cerebral complications, but we
believe that these factors play an important role in the mortality.</p><p>Various palliative procedures have been described in the literature. About 18.75% of
our patients had undergone palliation procedures previously, which were taken down
and a definitive repair performed. Published reports for repairs for ToF previously
in Pakistan show a small number of patients being palliated alluding to the fact
that the congenital cardiac surgery was in its initial stages in those days in this
part of the world.</p><p>Most of the advanced centers in the world would perform a primary repair provided
there are no contraindications, but there is still no consensus on this subject.
Proponents of the primary repair argue that it avoids RV dysfunction and cyanotic
spells which can delay developmental milestones. These patients are also prone to
cerebral complications like stroke and intracerebral abscess formation. Only 15
patients in our study had undergone a previous palliative procedure and the rest
underwent a primary repair in adulthood. Navabi-Shirazi et al.<sup>[<xref rid="B9" ref-type="bibr">9</xref>]</sup> compared results of primary repair
and those who had undergone some kind of palliation previously. They concluded that
older patients generally do better on 2-stage repair, because of their age, but
there is no conclusive data available that demonstrate that twostage repair with
improvement of oxygen saturation before correction may improve outcome in this
selected group of adult patients. Our study shows no mortality in the group, which
had undergone palliation procedures previously.</p><p>TAP is needed for a very small-sized pulmonary valve. It carries a higher risk of
reoperation, but has no impact on late survival<sup>[<xref rid="B10" ref-type="bibr">10</xref>]</sup>. We applied TAP in a comparatively high number of
patients. The reason was we did not accept high degree of right ventricle/left
ventricle pressure ratio and the goal was to relieve RVOT as much as
possible<sup>[<xref rid="B11" ref-type="bibr">11</xref>]</sup>. Some authors
have reported that the use of TAP is lower in grown patients<sup>[<xref rid="B12" ref-type="bibr">12</xref>]</sup>. Apart from a definitive
indication based on size, which patient would benefit from a TAP is not fully know.
Although this question would be best answered with a prospective randomized study,
our experience suggests that the severity of the RVOT, rather than age at repair, is
the most important determinant of the frequency of use of TAP.</p><p>TAP relieves the RVOT but, at the same time, it can cause varying degree of PR, which
is associated with poor short and long-term outcome<sup>[<xref rid="B13" ref-type="bibr">13</xref>]</sup>. PR observed postoperatively in our study was
25%, which is consistent with published reports<sup>[<xref rid="B14" ref-type="bibr">14</xref>]</sup>. A large study by Kirklin et al.<sup>[<xref rid="B15" ref-type="bibr">15</xref>]</sup> suggested that the compensatory
responses to RV overload were adequate for a 20-year period, at least with respect
to mortality. Our data extend these observations and do not demonstrate any
difference in early survival among patients without a patch, and those with a TAP,
although other investigators have implicated TAP as a risk factor for reoperation in
the long term.</p><p>ToF repair in adults carry more postoperative morbidity rate compared to early
repair<sup>[<xref rid="B16" ref-type="bibr">16</xref>]</sup>. Complications
like low cardiac output syndrome, pericardial effusion, atelectasis, atrial
arrhythmia, reoperation for bleeding and varying degree of PR were encountered in
our patients. The incidence of postoperative atrial arrhythmias was higher in our
adult patients compared to paediatrics as reported in the literature<sup>[<xref rid="B17" ref-type="bibr">17</xref>]</sup>. The incidence of junctional
ectopic tachycardia and persistent complete heart block reported in literature is 2%
and 1%, respectively<sup>[<xref rid="B18" ref-type="bibr">18</xref>]</sup>. Lungs
related complications were encountered in 3.75% of our patients. Kim et
al.<sup>[<xref rid="B19" ref-type="bibr">19</xref>]</sup> reported a 5%
incidence of pleural effusion that required tapping. The surgical techniques for
primary repair to preserve RV function, reduce arrhythmia, and optimize functional
status that are still evolving and a definitive consensus is lacking<sup>[<xref rid="B20" ref-type="bibr">20</xref>]</sup>.</p><p>Our study is not without limitations. A retrospective design and limited follow-up
are some of the drawbacks. However, on the other hand, this study gives an insight
to the contemporary adult cardiac surgery being practiced in Pakistan. We hope that
more centers will publish their results with long-term follow-up. Especially the
fate of PR and treatment strategies in our patient population needs to be
ascertained. Secondly, with improvement in expertise and perioperative management in
Pakistan, more and more surgeons will opt for early primary repair of ToF.</p><table-wrap id="t4" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="10%" span="1"/><col width="90%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Authors&#x02019; roles &#x00026; responsibilities</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">IK</td><td align="left" rowspan="1" colspan="1">Final manuscript approval</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ZT</td><td align="left" rowspan="1" colspan="1">Realization of operations and/or trials; final
manuscript approval</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">SA</td><td align="left" rowspan="1" colspan="1">Realization of operations and/or trials; final
manuscript approval</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MI</td><td align="left" rowspan="1" colspan="1">Analysis and/or data interpretation; statistical
analysis; final manuscript approval</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">TK</td><td align="left" rowspan="1" colspan="1">Realization of operations and/or trials; final
manuscript approval</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">AW</td><td align="left" rowspan="1" colspan="1">Final manuscript approval</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn><fn fn-type="other"><p>This study was carried out at the Punjab Institute of Cardiology, Lahore,
Pakistan.</p></fn><fn fn-type="supported-by"><p>No financial support.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wald</surname><given-names>RM</given-names></name><name><surname>Altaha</surname><given-names>MA</given-names></name><name><surname>Alvarez</surname><given-names>N</given-names></name><name><surname>Caldarone</surname><given-names>CA</given-names></name><name><surname>Cavall&#x000e9;-Garrido</surname><given-names>T</given-names></name><name><surname>Dallaire</surname><given-names>F</given-names></name><etal/></person-group><article-title>Rationale and design of the Canadian Outcomes Registry Late After
Tetralogy of Fallot Repair the CORRELATE study</article-title><source>Can J Cardiol</source><year>2014</year><volume>30</volume><issue>11</issue><fpage>1436</fpage><lpage>1443</lpage><pub-id pub-id-type="pmid">25239650</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bertranou</surname><given-names>EG</given-names></name><name><surname>Blackstone</surname><given-names>EH</given-names></name><name><surname>Hazelrig</surname><given-names>JB</given-names></name><name><surname>Turner</surname><given-names>ME</given-names></name><name><surname>Kirklin</surname><given-names>JW</given-names></name></person-group><article-title>Life expectancy without surgery in tetralogy of
Fallot</article-title><source>Am J Cardiol</source><year>1978</year><volume>42</volume><issue>3</issue><fpage>458</fpage><lpage>466</lpage><pub-id pub-id-type="pmid">685856</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>RH</given-names></name><name><surname>Sarwark</surname><given-names>A</given-names></name><name><surname>Spicer</surname><given-names>DE</given-names></name><name><surname>Backer</surname><given-names>CL</given-names></name></person-group><chapter-title>Exercises in anatomy: tetralogy of Fallot</chapter-title><source>Multimed Man Cardiothorac Surg</source><volume>2014</volume><year>2014</year></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villafa&#x000f1;e</surname><given-names>J</given-names></name><name><surname>Feinstein</surname><given-names>JA</given-names></name><name><surname>Jenkins</surname><given-names>KJ</given-names></name><name><surname>Vincent</surname><given-names>RN</given-names></name><name><surname>Walsh</surname><given-names>EP</given-names></name><name><surname>Dubin</surname><given-names>AM</given-names></name><etal/></person-group><person-group person-group-type="author"><collab>Adult Congenital and Pediatric Cardiology Section</collab><collab>American College of Cardiology</collab></person-group><article-title>Hot topics in tetralogy of Fallot</article-title><source>J Am Coll Cardiol</source><year>2013</year><volume>62</volume><issue>23</issue><fpage>2155</fpage><lpage>2166</lpage><pub-id pub-id-type="pmid">24076489</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Olley</surname><given-names>PM</given-names></name></person-group><chapter-title>Follow-up of children treated with intracardiac repair for
Tetralogy of Fallot</chapter-title><person-group person-group-type="editor"><name><surname>Kidd</surname><given-names>BSL</given-names></name><name><surname>Keit</surname><given-names>JD</given-names></name></person-group><source>The natural history and progress in treatment of congenital heart
defect</source><publisher-loc>Springfield</publisher-loc><publisher-name>Charles. C Thomas Publisher</publisher-name><year>1971</year><fpage>195</fpage><lpage>195</lpage></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dittrich</surname><given-names>S</given-names></name><name><surname>Vogel</surname><given-names>M</given-names></name><name><surname>D&#x000e4;hnert</surname><given-names>I</given-names></name><name><surname>Berger</surname><given-names>F</given-names></name><name><surname>Alexi-Meskishvili</surname><given-names>V</given-names></name><name><surname>Lange</surname><given-names>PE</given-names></name></person-group><article-title>Surgical repair of tetralogy of Fallot in adults
today</article-title><source>Clin Cardiol</source><year>1999</year><volume>22</volume><issue>7</issue><fpage>460</fpage><lpage>464</lpage><pub-id pub-id-type="pmid">10410289</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>C</given-names></name><name><surname>Lee</surname><given-names>CN</given-names></name><name><surname>Kim</surname><given-names>SC</given-names></name><name><surname>Lim</surname><given-names>C</given-names></name><name><surname>Chang</surname><given-names>YH</given-names></name><name><surname>Kang</surname><given-names>CH</given-names></name><etal/></person-group><article-title>Outcome after one-stage repair of tetralogy of
Fallot</article-title><source>J Cardiovasc Surg (Torino)</source><year>2006</year><volume>47</volume><issue>1</issue><fpage>65</fpage><lpage>70</lpage></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tchoumi</surname><given-names>JC</given-names></name><name><surname>Ambassa</surname><given-names>JC</given-names></name><name><surname>Giamberti</surname><given-names>A</given-names></name><name><surname>Cirri</surname><given-names>S</given-names></name><name><surname>Frogiola</surname><given-names>A</given-names></name><name><surname>Butera</surname><given-names>G</given-names></name></person-group><article-title>Late surgical treatment of tetralogy of Fallot</article-title><source>Cardiovasc J Afr</source><year>2011</year><volume>22</volume><issue>4</issue><fpage>179</fpage><lpage>181</lpage><pub-id pub-id-type="pmid">21881681</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Navabi Shirazi</surname><given-names>MA</given-names></name><name><surname>Ghavanini</surname><given-names>AA</given-names></name><name><surname>Sajjadi</surname><given-names>S</given-names></name></person-group><article-title>Early postoperative results after total correction of tetralogy
of Fallot in older patients is primary repair always
justified?</article-title><source>Pediatr Cardiol</source><year>2001</year><volume>22</volume><issue>3</issue><fpage>238</fpage><lpage>241</lpage><pub-id pub-id-type="pmid">11343152</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ylitalo</surname><given-names>P</given-names></name><name><surname>Nieminen</surname><given-names>H</given-names></name><name><surname>Pitk&#x000e4;nen</surname><given-names>OM</given-names></name><name><surname>Jokinen</surname><given-names>E</given-names></name><name><surname>Sairanen</surname><given-names>H</given-names></name></person-group><article-title>Need of transannular patch in tetralogy of Fallot surgery carries
a higher risk of reoperation but has no impact on late survival results of
Fallot repair in Finland</article-title><source>Eur J Cardiothorac Surg</source><year>2015</year><volume>48</volume><issue>1</issue><fpage>91</fpage><lpage>97</lpage><pub-id pub-id-type="pmid">25326015</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pacifico</surname><given-names>AD</given-names></name><name><surname>Kirklin</surname><given-names>JW</given-names></name><name><surname>Blackstone</surname><given-names>EH</given-names></name></person-group><article-title>Surgical management of pulmonary stenosis in tetralogy of
Fallot</article-title><source>J Thorac Cardiovasc Surg</source><year>1977</year><volume>74</volume><issue>3</issue><fpage>382</fpage><lpage>395</lpage><pub-id pub-id-type="pmid">895172</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vobecky</surname><given-names>SJ</given-names></name><name><surname>Williams</surname><given-names>WG</given-names></name><name><surname>Trusler</surname><given-names>GA</given-names></name><name><surname>Coles</surname><given-names>JG</given-names></name><name><surname>Rebeyka</surname><given-names>IM</given-names></name><name><surname>Smallhorn</surname><given-names>J</given-names></name><etal/></person-group><article-title>Survival analysis of infants under age 18 months presenting with
tetralogy of Fallot</article-title><source>Ann Thorac Surg</source><year>1993</year><volume>56</volume><issue>4</issue><fpage>944</fpage><lpage>949</lpage><pub-id pub-id-type="pmid">7692831</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mavroudis</surname><given-names>CD</given-names></name><name><surname>Frost</surname><given-names>J</given-names></name><name><surname>Mavroudis</surname><given-names>C</given-names></name></person-group><article-title>Pulmonary valve preservation and restoration strategies for
repair of tetralogy of Fallot</article-title><source>Cardiol Young</source><year>2014</year><volume>24</volume><issue>6</issue><fpage>1088</fpage><lpage>1094</lpage><pub-id pub-id-type="pmid">25647383</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>DW</given-names></name><name><surname>Shao</surname><given-names>GF</given-names></name><name><surname>Feng</surname><given-names>Q</given-names></name><name><surname>Ni</surname><given-names>YM</given-names></name></person-group><article-title>Long-term outcome of correction of tetralogy of Fallot in 56
adult patients</article-title><source>Chin Med J (Engl)</source><year>2013</year><volume>126</volume><issue>19</issue><fpage>3675</fpage><lpage>3679</lpage><pub-id pub-id-type="pmid">24112162</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirklin</surname><given-names>JK</given-names></name><name><surname>Kirklin</surname><given-names>JW</given-names></name><name><surname>Blackstone</surname><given-names>EH</given-names></name><name><surname>Milano</surname><given-names>A</given-names></name><name><surname>Pacifico</surname><given-names>AD</given-names></name></person-group><article-title>Effect of transannular patching on outcome after repair of
tetralogy of Fallot</article-title><source>Ann Thorac Surg</source><year>1989</year><volume>48</volume><issue>6</issue><fpage>783</fpage><lpage>791</lpage><pub-id pub-id-type="pmid">2596914</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>JG</given-names></name><name><surname>Gersh</surname><given-names>BJ</given-names></name><name><surname>Mair</surname><given-names>DD</given-names></name><name><surname>Fuster</surname><given-names>V</given-names></name><name><surname>McCoon</surname><given-names>MD</given-names></name><name><surname>llstrup</surname><given-names>DM</given-names></name><etal/></person-group><article-title>Long-term outcome in patients undergoing surgical repair of
tetralogy of Fallot</article-title><source>N Engl J Med</source><year>1993</year><volume>329</volume><issue>9</issue><fpage>593</fpage><lpage>599</lpage><pub-id pub-id-type="pmid">7688102</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cullen</surname><given-names>S</given-names></name><name><surname>Celermajer</surname><given-names>DS</given-names></name><name><surname>Franklin</surname><given-names>RC</given-names></name><name><surname>Hallidie-Smith</surname><given-names>KA</given-names></name><name><surname>Deanfield</surname><given-names>JE</given-names></name></person-group><article-title>Prognostic significance of ventricular arrhythmia after repair of
tetralogy of Fallot a 12-year prospective study</article-title><source>J Am Coll Cardiol</source><year>1994</year><volume>23</volume><issue>5</issue><fpage>1151</fpage><lpage>1155</lpage><pub-id pub-id-type="pmid">8144782</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Egbe</surname><given-names>AC</given-names></name><name><surname>Uppu</surname><given-names>SC</given-names></name><name><surname>Mittnacht</surname><given-names>AJ</given-names></name><name><surname>Joashi</surname><given-names>U</given-names></name><name><surname>Ho</surname><given-names>D</given-names></name><name><surname>Nguyen</surname><given-names>K</given-names></name><etal/></person-group><article-title>Primary tetralogy of Fallot repair predictors of intensive care
unit morbidity</article-title><source>Asian Cardiovasc Thorac Ann</source><year>2014</year><volume>22</volume><issue>7</issue><fpage>794</fpage><lpage>799</lpage><pub-id pub-id-type="pmid">24887913</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>H</given-names></name><name><surname>Sung</surname><given-names>SC</given-names></name><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Chang</surname><given-names>YH</given-names></name><name><surname>Lee</surname><given-names>HD</given-names></name><name><surname>Park</surname><given-names>JA</given-names></name><etal/></person-group><article-title>Early and late outcomes of total repair of tetralogy of Fallot
risk factors for late right ventricular dilatation</article-title><source>Interact Cardiovasc Thorac Surg</source><year>2013</year><volume>17</volume><issue>6</issue><fpage>956</fpage><lpage>962</lpage><pub-id pub-id-type="pmid">23956267</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alexiou</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Galogavrou</surname><given-names>M</given-names></name><name><surname>Gnanapragasam</surname><given-names>J</given-names></name><name><surname>Salmon</surname><given-names>AP</given-names></name><name><surname>Keeton</surname><given-names>BR</given-names></name><etal/></person-group><article-title>Repair of tetralogy of Fallot in infancy with a transventricular
or a transatrial approach</article-title><source>Eur J Cardiothorac Surg</source><year>2002</year><volume>22</volume><issue>2</issue><fpage>174</fpage><lpage>183</lpage><pub-id pub-id-type="pmid">12142182</pub-id></element-citation></ref></ref-list></back></article>